New report details five key trends slated to impact the future, project leaders, and change-makers around the world

PHILADELPHIA-Tuesday 9 February 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- Project Management Institute (PMI) has released its latest report on long-term business, geopolitical, and technological trends that are reshaping our world and the types of projects that will be most prevalent and critical in the years to come in the face of these disruptions. Megatrends 2021 helps to ensure that project leaders can better understand the world’s rapid transformation and the global context in which they are working today.

“We know the world changed significantly in 2020, but our research confirmed the long-term impact of how these trends are changing how the world does business,” said Sunil Prashara, President and CEO of Project Management Institute. “There is virtually no industry and no geography that is untouched by the five megatre ... Read more »

LAUSANNE, Switzerland-Tuesday 9 February 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE: PM) today announced that its Board of Directors has appointed a new member, Mr. Bonin Bough, effective immediately.

Bonin Bough, 43, an American businessman, is the founder and Chief Growth Officer of growth accelerator Bonin Ventures. He has been Chief Growth and Marketing Officer of Sundial Brands (Unilever); television host of CNBC’s “Cleveland Hustles”; Chief Media and E-Commerce Officer of Mondelez International; Vice President, Global Media and Consumer Engagement of Kraft Foods Group; and Chief Digital Officer of PepsiCo.

Mr. Lucio Noto, PMI’s interim Chairman, congratulated Mr. Bough on his appointment and said, “It is with great pleasure that we welcome a member of the new generation of digital-first executives to the Philip Morris International Board of Directors. As we move forward to ‘unsm ... Read more »

 The largest incentive prize in history to attract and inspire innovators to develop and scale carbon removal solutions to combat climate change.

LOS ANGELES-Tuesday 9 February 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- XPRIZE, the world’s leader in designing and launching incentive competitions to solve humanity’s grand challenges, today announced the $100M XPRIZE Carbon Removal sponsored by Elon Musk and the Musk Foundation.

This four-year global competition invites innovators and teams from anywhere on the planet to create and demonstrate a solution that can pull carbon dioxide directly from the atmosphere or oceans and lock it away permanently in an environmentally benign way. To win the competition, teams must demonstrate a rigorous, validated scale model of their solution at a level of carbon removal of 1 ton of CO2 per day, and further must demonstrate to a team of judges the ability of their solution to economically scale to gigaton levels ... Read more »

Enexor BioEnergy, Momentum Technologies and OCO Inc. join clean tech accelerator program

HOUSTON-Tuesday 9 February 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Halliburton Labs today announced the inaugural group of companies selected to participate in its collaborative environment where entrepreneurs, academics, and investors come together to advance cleaner, affordable energy. Enexor BioEnergy, Momentum Technologies and OCO Inc. will have access to Halliburton’s deep business and technical expertise, facilities and network to accelerate their respective offerings.

“We are excited to welcome a strong group of companies who have demonstrated promising innovation and are working to solve important clean energy challenges,” said Dale Winger, managing director of Halliburton Labs. “We look forward to collaborating with these companies and providing world-class industrial capabilities and expertise to help them achieve further scale.”

NEW YORK-Tuesday 9 February 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- Moody’s Analytics has earned the top ranking in four categories in the new Center for Financial Professionals (CeFPro) Fintech Leaders 2021 report:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210209005319/en/

» #1: Balance Sheet Risk
» #1: Credit Risk
» #1: Model Risk
» #1: Stress Testing

As a result of these wins we finished #2 in the report’s Top 50 Overall Ecosystem Rankings, up from #5 last year.

“Addressing uncertainty is an elemental challenge for all of our customers, irrespective of the specific parts of their business we support. That was the case before the pandemic and is even more so now,” said Jacob Grotta, Head of Banking Solutions at Moody’s Analytics. “We’re proud that our customers choose Moody’s Analytics to ... Read more »

BEIJING-Tuesday 9 February 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Chinese President Xi Jinping has sent New Year's greetings to Chinese people of all ethnic groups, wishing happiness and good fortune for the people and prosperity for the nation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210208005631/en/

President Xi, also general secretary of the Communist Party of China Central Committee, extended the greetings during an inspection trip in southwest China's Guizhou Province prior to the Chinese New Year, which falls on February 12 this year.

"I'd like to extend Spring Festival blessings to people of all ethnic groups across the country. I wish everyone good health, happiness for their families, successful careers, and an auspicious Year of the Ox. I also wish our great motherland, with its beautiful mountains and rivers, much prosperity," Xi said.

During h ... Read more »

• Umbralisib (UKONIQ™) granted accelerated approval by US FDA for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL), follicular lymphoma (FL).

• Umbralisib, a novel next generation inhibitor of PI3K delta & CK1 epsilon, was discovered by Rhizen Pharmaceuticals and subsequently licensed to TG Therapeutics, who led the asset’s clinical development.

• Rhizen and its affiliate Alembic Pharma to support TG Therapeutics towards UKONIQ’s commercialization as its manufacturing & supply partner; Rhizen plans to register and commercialize Umbralisib in India.

BASEL, Switzerland-Tuesday 9 February 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Rhizen Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company, today announced that its novel next generation PI3K-delta inhibitor, Umbralisib, which was licensed to TG Therapeutics (NASDAQ:TGTX), has secured US FDA accelerated app ... Read more »